Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents
Open Access
- 1 September 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (1), 92-99
- https://doi.org/10.1038/sj.bjp.0706840
Abstract
Background and purpose: Trefoil factors (TFFs) secreted by mucus‐producing cells are essential for the defence of the gastrointestinal mucosa. TFFs probably influence the viscoelastic properties of mucus, but this has not been demonstrated in vivo. We therefore studied the gastric secretion of systemically administered TFF2 and TFF3, and their influence on the viscosity of the secretions. Experimental approach: Mice and rats under general anaesthesia were injected intravenously with human (h) TFF2, hTFF3 (5 mg kg−1 to mice and 25 mg kg−1 to rats), murine (m) 125I‐TFF3, or 125I‐hTFF3 (300 000 cpm, mice only). The appearance of TFFs in the gastric mucosa and luminal secretions was analysed by autoradiography, gamma‐counting, and ELISA, and the viscosity by rheometry. Key results: 125I‐mTFF3 and 125I‐hTFF3 were taken up by secretory cells of the gastrointestinal tract and detected at the gastric mucosal surface 15 min after injection. Stressing the stomach by carbachol (3.5 μg kg−1) and pyloric ligation significantly increased the uptake. Injected hTFF2, hTFF3, and mTFF3 were retrieved from the gastric contents after 4 h. In rats, an approximately seven‐fold increase in the viscosity was detected after injection of TFF2 compared to the controls, whereas TFF3 did not increase the viscosity. In mice, TFF2 increased the viscosity approximately 4‐fold. Conclusions: These data indicate that systemically administered TFFs are transferred to the gastric lumen in a biologically active form. British Journal of Pharmacology (2006) 149, 92–99. doi:10.1038/sj.bjp.0706840Keywords
This publication has 30 references indexed in Scilit:
- Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Trefoil factors: initiators of mucosal healingNature Reviews Molecular Cell Biology, 2003
- The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomachGut, 2000
- Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoproteinGastroenterology, 1995
- Structure and Expression of Murine Intestinal Trefoil Factor: High Evolutionary Conservation and Postnatal ExpressionBiochemical and Biophysical Research Communications, 1995
- Characterization of Human and Rat Intestinal Trefoil Factor Produced in YeastBiochemistry, 1995
- Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migrationGastroenterology, 1995
- Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.Journal of Clinical Investigation, 1994
- Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeastFEBS Letters, 1993
- A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)FEBS Letters, 1989